Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-24 4:42 pm Purchase | 2025-06-20 | 13D | Nautilus Biotechnology, Inc. NAUT | Perceptive Advisors LLC | 12,815,113 10.100% | 220,902 (+1.75%) | Filing History |
| 2025-06-04 4:05 pm Sale | 2025-06-02 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Perceptive Advisors LLC | 0 0.000% | -3,104,139 (Position Closed) | Filing History |
| 2025-05-15 6:20 pm Sale | 2025-03-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | Perceptive Advisors LLC | 4,423,441 6.800% | -1,011,769 (-18.62%) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Perceptive Advisors LLC | 7,874,348 8.800% | 1,100,000 (+16.24%) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | Bright Minds Biosciences Inc. DRUG | Perceptive Advisors LLC | 444,649 6.300% | 14,649 (+3.41%) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | Beta Bionics, Inc. BBNX | Perceptive Advisors LLC | 2,203,840 5.100% | 2,203,840 (New Position) | Filing History |
| 2025-05-15 4:30 pm Sale | 2025-03-31 | 13G | Amicus Therapeutics, Inc. FOLD | Perceptive Advisors LLC | 21,464,527 7.000% | -2,781,425 (-11.47%) | Filing History |
| 2025-05-15 4:30 pm Unchanged | 2025-03-31 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | Perceptive Advisors LLC | 1,441,249 7.500% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:30 pm Sale | 2025-03-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 148,148 1.600% | -324,967 (-68.69%) | Filing History |
| 2025-05-15 4:30 pm Sale | 2025-03-31 | 13G | Arcellx, Inc. ACLX | Perceptive Advisors LLC | 2,926,478 5.300% | -962,191 (-24.74%) | Filing History |
| 2025-05-15 4:30 pm Sale | 2025-03-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Perceptive Advisors LLC | 980,894 4.800% | -848,841 (-46.39%) | Filing History |
| 2025-05-15 4:30 pm Unchanged | 2025-03-31 | 13G | Surrozen, Inc. SRZN | Perceptive Advisors LLC | 166,666 1.900% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | Outset Medical, Inc. OM | Perceptive Advisors LLC | 1,208,334 6.700% | 1,208,334 (New Position) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | Edgewise Therapeutics, Inc. EWTX | Perceptive Advisors LLC | 6,395,546 6.100% | 1,231,059 (+23.84%) | Filing History |
| 2025-05-15 4:30 pm Sale | 2025-03-31 | 13G | Evolus, Inc. EOLS | Perceptive Advisors LLC | 4,129,142 6.400% | -1,227,480 (-22.92%) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-05-12 | 13G | Biodesix, Inc. BDSX | Perceptive Advisors LLC | 383,694 5.100% | 50,000 (+14.98%) | Filing History |
| 2025-05-15 4:30 pm Unchanged | 2025-03-31 | 13G | Ensysce Biosciences, Inc. ENSC | Perceptive Advisors LLC | 86,666 3.700% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:30 pm Sale | 2025-03-31 | 13G | Instil Bio, Inc. TIL | Perceptive Advisors LLC | 0 0.000% | -345,545 (Position Closed) | Filing History |
| 2025-05-15 4:30 pm Sale | 2025-03-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | Perceptive Advisors LLC | 12,808,788 3.800% | -9,303,478 (-42.07%) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | Traws Pharma, Inc. TRAW | Perceptive Advisors LLC | 545,197 9.990% | 158,642 (+41.04%) | Filing History |